Clinical Trial

A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 25, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the absorption, metabolism, and excretion of a single oral dose of \[¹⁴C\]SSS17 in healthy adult Chinese male subjects, elucidating its overall pharmacokinetic profile in humans to provide essential information for its rational clinical use.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-17.
Trial Details
NCT Number NCT07025915
Lead Sponsor Shenyang Sunshine Pharmaceutical Co., LTD.
Conditions Healthy Subjects (HS)
Enrollment 6 participants
Start Date 2025-06
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-06-25